CN105461807B - 肿瘤相关基因tp53表位多肽单克隆抗体及其应用 - Google Patents
肿瘤相关基因tp53表位多肽单克隆抗体及其应用 Download PDFInfo
- Publication number
- CN105461807B CN105461807B CN201610024192.9A CN201610024192A CN105461807B CN 105461807 B CN105461807 B CN 105461807B CN 201610024192 A CN201610024192 A CN 201610024192A CN 105461807 B CN105461807 B CN 105461807B
- Authority
- CN
- China
- Prior art keywords
- monoclonal antibody
- antibody
- epitope
- immunogene
- pgtrvrqsqhmtelirvec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4748—Details p53
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610024192.9A CN105461807B (zh) | 2016-01-15 | 2016-01-15 | 肿瘤相关基因tp53表位多肽单克隆抗体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610024192.9A CN105461807B (zh) | 2016-01-15 | 2016-01-15 | 肿瘤相关基因tp53表位多肽单克隆抗体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105461807A CN105461807A (zh) | 2016-04-06 |
CN105461807B true CN105461807B (zh) | 2018-04-06 |
Family
ID=55600007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610024192.9A Active CN105461807B (zh) | 2016-01-15 | 2016-01-15 | 肿瘤相关基因tp53表位多肽单克隆抗体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105461807B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113861283A (zh) * | 2021-03-24 | 2021-12-31 | 深圳市新靶向生物科技有限公司 | 一种与肺癌驱动基因突变相关的抗原肽及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103255128A (zh) * | 2013-04-27 | 2013-08-21 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 多种抗原免疫高通量制备单克隆抗体及其杂交瘤细胞株的方法 |
-
2016
- 2016-01-15 CN CN201610024192.9A patent/CN105461807B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN105461807A (zh) | 2016-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11155632B2 (en) | Anti-CD47 monoclonal antibody and use thereof | |
Campoli et al. | Functional and clinical relevance of chondroitin sulfate proteoglycan 4 | |
KR102312856B1 (ko) | Ror1 암을 치료하고 전이를 저해하는데 이용을 위한 항체와 백신 | |
CN103003424B (zh) | 结合转化生长因子α且对Ras基因突变的癌具有增殖抑制活性的抗体 | |
EA015534B1 (ru) | Антитела к миостатину и способы их применения | |
CN109438576B (zh) | 一种抗人cd47单克隆抗体的制备及其应用 | |
JP2009515827A (ja) | 治療薬 | |
CN108699149A (zh) | 抗-ror1抗体及其用途 | |
CN104395342B (zh) | 人源抗纤连蛋白ed‑b结构域的抗体及其用途 | |
CN110121509A (zh) | 中和抗tl1a单克隆抗体 | |
CN102847148A (zh) | 结合细胞内prl-1多肽或prl-3多肽的抗体 | |
CN109776678A (zh) | 一种人源化pd-l1单克隆抗体、其制备方法和应用 | |
CN101970472A (zh) | Rtef-1变体及其用于抑制血管发生的用途 | |
CN109069630A (zh) | 使用免疫检测点调节剂和共生微生物菌丛的发酵产物的结合癌症疗法 | |
CN106866820B (zh) | 一种用于捕获肿瘤细胞的抗人角蛋白18的单克隆抗体及其应用 | |
EP1544293A1 (en) | Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same | |
CN109071668A (zh) | 抗n-乙酰基葡萄糖胺和n-乙酰基-半乳糖胺的抗体 | |
CN105461807B (zh) | 肿瘤相关基因tp53表位多肽单克隆抗体及其应用 | |
CN103333247A (zh) | 新型抗vegfr2的单克隆抗体及其制备与应用 | |
CN109337903A (zh) | 一种长链非编码RNA lncRNA-6585及其抗体与应用 | |
CN101864398A (zh) | 一种抗促性腺激素释放激素受体的单克隆抗体与应用 | |
CN105017425B (zh) | 抗her2中和活性单克隆抗体及其应用 | |
CN104592386B (zh) | Ets结构域转录因子fev蛋白单克隆抗体及其应用 | |
CN103130896B (zh) | 抗细胞表面异位表达的单克隆抗体及其制备方法和用途 | |
CN107522785A (zh) | 抗egfr突变体iii单克隆抗体、制备方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Lianbo Inventor after: Sun Shilong Inventor after: Liu Ying Inventor after: Zhang Yurou Inventor after: Fu Yichen Inventor before: Zhang Lianbo Inventor before: Sun Shilong Inventor before: Liu Ying |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Guang Inventor after: Zhang Lianbo Inventor after: Sun Shilong Inventor after: Liu Ying Inventor after: Zhang Yurou Inventor after: Fu Yichen Inventor before: Zhang Lianbo Inventor before: Sun Shilong Inventor before: Liu Ying Inventor before: Zhang Yurou Inventor before: Fu Yichen |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |